血清淀粉樣P物質(zhì)(SAP)多克隆抗體
Polyclonal Antibody to Serum Amyloid P Component (SAP)
APCS; PTX2; Pentaxin-Related; 9.5S Alpha-1-Glycoprotein
- 編號PAB539Ra01
- 物種Rattus norvegicus (Rat,大鼠)相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原RPB539Ra01-血清淀粉樣P物質(zhì)(SAP)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度500μg/mL
- 且適物種Homo sapiens (Human,人)
- 應(yīng)用WB; IHC
如果抗體需用于流式細(xì)胞術(shù),請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 652 ¥ 1520¥ 2172¥ 5430¥ 21720
- 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對SAP的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別SAP。
用法
Western blotting: 0.5-2μg/mL;1:500-2000
Immunohistochemistry: 5-20μg/mL;1:50-200
Immunocytochemistry: 5-20μg/mL;1:50-200
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB539Ra01 | 血清淀粉樣P物質(zhì)(SAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB539Ra01 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體 | WB; IHC |
MAB539Ra21 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
SEB539Ra | 血清淀粉樣P物質(zhì)(SAP)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB539Ra | 血清淀粉樣P物質(zhì)(SAP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Journal of Vascular Surgery | Circulation levels of acute phase proteins in patients with Takayasu arteritis[PubMed: 20100644] |
Journal of Proteome Research | Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes[ACS: pr2005555] |
Liver International | Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 3-D DIGE[Pubmed: 23944848] |
Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study[pubmed:28112944] |
American Journal of Reproductive Immunology | Amniotic fluid pentraxins: Potential early markers for identifying intra‐amniotic inflammatory complications in preterm pre‐labor rupture of membranes[pubmed:29193454] |
Theranostics | Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages[Pubmed:29930724] |
J Med Primatol | Proteopathic lesions in the brain of a super?\aged chimpanzee (Pan troglodytes)[34096618] |
Clinical and Experimental Immunology | Clinical significance of differential serum-signatures for early prediction of severe dengue among Eastern Indian patients[Pubmed:35348620] |